| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 38 | 2024 | 1537 | 5.830 |
Why?
|
| Aldosterone | 15 | 2023 | 877 | 3.300 |
Why?
|
| Pulmonary Artery | 16 | 2023 | 1912 | 2.050 |
Why?
|
| Glucosephosphate Dehydrogenase | 16 | 2020 | 207 | 2.010 |
Why?
|
| Vascular Diseases | 10 | 2022 | 1161 | 1.700 |
Why?
|
| Endothelium, Vascular | 22 | 2017 | 4456 | 1.510 |
Why?
|
| Muscle, Smooth, Vascular | 14 | 2020 | 1504 | 1.460 |
Why?
|
| Oxidative Stress | 20 | 2016 | 3086 | 1.220 |
Why?
|
| Ventricular Dysfunction, Right | 9 | 2023 | 581 | 1.210 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 6 | 2021 | 127 | 1.050 |
Why?
|
| Ventricular Function, Right | 7 | 2023 | 591 | 1.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2022 | 1873 | 1.030 |
Why?
|
| Pulmonary Circulation | 5 | 2022 | 739 | 1.010 |
Why?
|
| Spironolactone | 8 | 2016 | 382 | 1.000 |
Why?
|
| Hemodynamics | 11 | 2023 | 4199 | 0.960 |
Why?
|
| Nitric Oxide | 12 | 2012 | 2132 | 0.910 |
Why?
|
| Neointima | 2 | 2014 | 135 | 0.910 |
Why?
|
| Myocytes, Smooth Muscle | 7 | 2020 | 687 | 0.860 |
Why?
|
| Hyperaldosteronism | 4 | 2023 | 240 | 0.840 |
Why?
|
| Cardiovascular Diseases | 13 | 2024 | 15165 | 0.820 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 164 | 0.800 |
Why?
|
| Vasoconstriction | 3 | 2022 | 597 | 0.770 |
Why?
|
| Glutathione Peroxidase | 8 | 2011 | 255 | 0.760 |
Why?
|
| Blood Vessels | 4 | 2016 | 1125 | 0.750 |
Why?
|
| Remote Sensing Technology | 1 | 2021 | 90 | 0.740 |
Why?
|
| Receptors, Mineralocorticoid | 4 | 2016 | 164 | 0.730 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2012 | 350 | 0.730 |
Why?
|
| Radiation Protection | 1 | 2023 | 419 | 0.720 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2021 | 235 | 0.720 |
Why?
|
| Reactive Oxygen Species | 17 | 2015 | 2077 | 0.700 |
Why?
|
| Coronary Vessels | 7 | 2020 | 3107 | 0.690 |
Why?
|
| Antioxidants | 11 | 2016 | 1663 | 0.680 |
Why?
|
| Heart Failure | 10 | 2023 | 10900 | 0.670 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 5 | 2021 | 314 | 0.660 |
Why?
|
| Calcinosis | 5 | 2020 | 1499 | 0.650 |
Why?
|
| Hypertension | 9 | 2024 | 8480 | 0.650 |
Why?
|
| Plague | 1 | 2018 | 22 | 0.630 |
Why?
|
| Coronary Artery Disease | 9 | 2023 | 6487 | 0.630 |
Why?
|
| Oxidants | 4 | 2013 | 164 | 0.620 |
Why?
|
| Coronary Angiography | 8 | 2022 | 4577 | 0.620 |
Why?
|
| Endothelial Cells | 9 | 2018 | 3479 | 0.620 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 8 | 2012 | 89 | 0.600 |
Why?
|
| MicroRNAs | 3 | 2020 | 3752 | 0.560 |
Why?
|
| Health Status Indicators | 1 | 2021 | 969 | 0.540 |
Why?
|
| Antigens, CD34 | 2 | 2018 | 657 | 0.540 |
Why?
|
| Autonomic Pathways | 1 | 2015 | 30 | 0.530 |
Why?
|
| Models, Cardiovascular | 2 | 2019 | 996 | 0.530 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2585 | 0.510 |
Why?
|
| Oxidoreductases | 2 | 2009 | 424 | 0.510 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2012 | 689 | 0.500 |
Why?
|
| Humans | 126 | 2024 | 744343 | 0.500 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2014 | 41 | 0.500 |
Why?
|
| Vascular Resistance | 4 | 2020 | 936 | 0.500 |
Why?
|
| Denervation | 1 | 2015 | 278 | 0.490 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 530 | 0.480 |
Why?
|
| Lung Diseases | 3 | 2021 | 1886 | 0.480 |
Why?
|
| Lipocalins | 1 | 2015 | 170 | 0.480 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 262 | 0.470 |
Why?
|
| Drug-Eluting Stents | 3 | 2017 | 753 | 0.470 |
Why?
|
| Ventricular Remodeling | 5 | 2016 | 1224 | 0.470 |
Why?
|
| Monocrotaline | 1 | 2013 | 26 | 0.470 |
Why?
|
| Phenylpropionates | 1 | 2013 | 30 | 0.460 |
Why?
|
| Pulmonary Veins | 2 | 2021 | 761 | 0.450 |
Why?
|
| Diphosphates | 1 | 2013 | 88 | 0.450 |
Why?
|
| Stem Cells | 4 | 2018 | 3567 | 0.440 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 264 | 0.430 |
Why?
|
| Cardiovascular System | 1 | 2020 | 832 | 0.430 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2006 | 641 | 0.430 |
Why?
|
| Receptor, Endothelin B | 1 | 2012 | 41 | 0.430 |
Why?
|
| Aorta | 6 | 2020 | 2061 | 0.420 |
Why?
|
| Pulmonary Wedge Pressure | 4 | 2024 | 264 | 0.420 |
Why?
|
| Metabolomics | 1 | 2021 | 1484 | 0.420 |
Why?
|
| Obesity, Abdominal | 1 | 2015 | 361 | 0.410 |
Why?
|
| Cardiac Output, Low | 1 | 2012 | 195 | 0.410 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 237 | 0.410 |
Why?
|
| Pyridazines | 1 | 2013 | 202 | 0.400 |
Why?
|
| Heart Ventricles | 6 | 2023 | 3821 | 0.400 |
Why?
|
| Vasodilation | 5 | 2016 | 944 | 0.400 |
Why?
|
| Neurotransmitter Agents | 1 | 2015 | 647 | 0.390 |
Why?
|
| Progeria | 1 | 2013 | 185 | 0.390 |
Why?
|
| Systems Biology | 2 | 2018 | 469 | 0.390 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2010 | 20 | 0.390 |
Why?
|
| Research Report | 3 | 2021 | 355 | 0.380 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 749 | 0.380 |
Why?
|
| Delayed Diagnosis | 1 | 2014 | 441 | 0.380 |
Why?
|
| Oxidation-Reduction | 11 | 2013 | 2187 | 0.370 |
Why?
|
| Biological Evolution | 1 | 2016 | 1076 | 0.370 |
Why?
|
| Diuretics | 1 | 2013 | 592 | 0.360 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 814 | 0.360 |
Why?
|
| Up-Regulation | 4 | 2020 | 4217 | 0.360 |
Why?
|
| Nanoparticles | 1 | 2021 | 1905 | 0.350 |
Why?
|
| Cells, Cultured | 18 | 2020 | 19229 | 0.350 |
Why?
|
| Microcirculation | 1 | 2014 | 1286 | 0.350 |
Why?
|
| Health Behavior | 1 | 2021 | 2636 | 0.350 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2010 | 179 | 0.340 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 1188 | 0.340 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2014 | 546 | 0.340 |
Why?
|
| Calcium | 2 | 2022 | 5756 | 0.340 |
Why?
|
| Vasodilator Agents | 4 | 2020 | 977 | 0.340 |
Why?
|
| Free Radicals | 1 | 2009 | 237 | 0.340 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2440 | 0.340 |
Why?
|
| Acute Coronary Syndrome | 2 | 2014 | 2337 | 0.340 |
Why?
|
| Computational Biology | 3 | 2021 | 3521 | 0.340 |
Why?
|
| Thrombosis | 6 | 2020 | 2968 | 0.340 |
Why?
|
| Serpins | 1 | 2010 | 247 | 0.330 |
Why?
|
| Animals | 56 | 2020 | 168757 | 0.330 |
Why?
|
| Health Status | 2 | 2021 | 4034 | 0.330 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2010 | 302 | 0.330 |
Why?
|
| Xanthine Oxidase | 2 | 2006 | 64 | 0.330 |
Why?
|
| Phenotype | 9 | 2023 | 16365 | 0.320 |
Why?
|
| Signal Transduction | 10 | 2021 | 23403 | 0.320 |
Why?
|
| Computer Simulation | 3 | 2021 | 6196 | 0.320 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1572 | 0.320 |
Why?
|
| Guanylate Cyclase | 1 | 2009 | 201 | 0.310 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 2046 | 0.310 |
Why?
|
| Disulfides | 2 | 2009 | 457 | 0.310 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 12072 | 0.300 |
Why?
|
| Proteomics | 1 | 2021 | 3638 | 0.300 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 675 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 4 | 2018 | 1351 | 0.300 |
Why?
|
| Coronary Stenosis | 2 | 2021 | 834 | 0.290 |
Why?
|
| Catheter Ablation | 2 | 2022 | 2758 | 0.290 |
Why?
|
| NADP | 4 | 2009 | 226 | 0.290 |
Why?
|
| Sleep | 2 | 2023 | 4623 | 0.280 |
Why?
|
| Osteoblasts | 1 | 2012 | 1166 | 0.280 |
Why?
|
| Lung | 7 | 2022 | 9856 | 0.280 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 482 | 0.280 |
Why?
|
| DNA Damage | 1 | 2016 | 2432 | 0.270 |
Why?
|
| Coronary Disease | 4 | 2021 | 6077 | 0.270 |
Why?
|
| Atherosclerosis | 3 | 2014 | 3445 | 0.260 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1144 | 0.260 |
Why?
|
| Oxygenases | 1 | 2005 | 60 | 0.260 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 1392 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 4554 | 0.260 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 143 | 0.250 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2021 | 290 | 0.250 |
Why?
|
| Cardiology | 1 | 2016 | 1668 | 0.250 |
Why?
|
| Myocardial Infarction | 6 | 2014 | 11727 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2021 | 3309 | 0.250 |
Why?
|
| Atrial Fibrillation | 3 | 2022 | 5034 | 0.250 |
Why?
|
| Cell Proliferation | 9 | 2020 | 10481 | 0.250 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2014 | 1390 | 0.250 |
Why?
|
| Rats | 14 | 2020 | 24260 | 0.240 |
Why?
|
| Apoptosis | 7 | 2016 | 9727 | 0.240 |
Why?
|
| Coronary Thrombosis | 2 | 2005 | 495 | 0.240 |
Why?
|
| Gene Transfer Techniques | 4 | 2016 | 1224 | 0.240 |
Why?
|
| Platelet Activation | 3 | 2010 | 673 | 0.240 |
Why?
|
| Tachyphylaxis | 1 | 2003 | 51 | 0.230 |
Why?
|
| Pulmonary Embolism | 1 | 2016 | 2376 | 0.230 |
Why?
|
| Nitro Compounds | 1 | 2003 | 74 | 0.230 |
Why?
|
| Complement Activation | 2 | 2020 | 453 | 0.230 |
Why?
|
| Fibrinolytic Agents | 2 | 2008 | 2158 | 0.230 |
Why?
|
| Dexamethasone | 1 | 2010 | 1951 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 2916 | 0.220 |
Why?
|
| Fibrosis | 4 | 2020 | 2029 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 1213 | 0.220 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2006 | 3068 | 0.220 |
Why?
|
| X-Rays | 1 | 2023 | 301 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2020 | 8301 | 0.220 |
Why?
|
| Cattle | 6 | 2012 | 3922 | 0.220 |
Why?
|
| Early Diagnosis | 1 | 2008 | 1184 | 0.220 |
Why?
|
| Wound Healing | 1 | 2013 | 2785 | 0.210 |
Why?
|
| Aortic Valve | 1 | 2012 | 1922 | 0.210 |
Why?
|
| Pterins | 1 | 2001 | 11 | 0.210 |
Why?
|
| Cyclic AMP | 3 | 2020 | 1472 | 0.210 |
Why?
|
| Male | 44 | 2024 | 350118 | 0.200 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2008 | 1261 | 0.200 |
Why?
|
| Obesity | 2 | 2014 | 12745 | 0.200 |
Why?
|
| Hydrodynamics | 2 | 2021 | 158 | 0.200 |
Why?
|
| Angina, Unstable | 2 | 2006 | 926 | 0.190 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 694 | 0.190 |
Why?
|
| Education | 2 | 2021 | 543 | 0.180 |
Why?
|
| Nitric Oxide Synthase | 5 | 2009 | 916 | 0.180 |
Why?
|
| Glutathione | 7 | 2016 | 589 | 0.180 |
Why?
|
| Lymphokines | 1 | 2003 | 949 | 0.180 |
Why?
|
| Treatment Outcome | 11 | 2023 | 63114 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 1 | 2012 | 1965 | 0.180 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 323 | 0.180 |
Why?
|
| Second Messenger Systems | 1 | 2020 | 206 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2006 | 851 | 0.170 |
Why?
|
| Ticlopidine | 1 | 2005 | 899 | 0.170 |
Why?
|
| Periodicity | 1 | 2000 | 363 | 0.170 |
Why?
|
| Hydrogen Peroxide | 3 | 2009 | 731 | 0.170 |
Why?
|
| Random Allocation | 2 | 2014 | 2429 | 0.170 |
Why?
|
| Endothelium | 2 | 2020 | 778 | 0.170 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18029 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1185 | 0.160 |
Why?
|
| Collagen Type III | 1 | 2018 | 90 | 0.160 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 154 | 0.160 |
Why?
|
| Forecasting | 2 | 2018 | 2951 | 0.160 |
Why?
|
| Superoxides | 5 | 2012 | 387 | 0.160 |
Why?
|
| Female | 35 | 2024 | 380194 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 528 | 0.150 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2017 | 46 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1676 | 0.150 |
Why?
|
| Hemorrhage | 2 | 2006 | 3461 | 0.150 |
Why?
|
| Glucose | 3 | 2016 | 4397 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 3798 | 0.150 |
Why?
|
| Dependovirus | 2 | 2019 | 706 | 0.150 |
Why?
|
| Azoles | 1 | 2016 | 20 | 0.150 |
Why?
|
| Organoselenium Compounds | 1 | 2016 | 22 | 0.150 |
Why?
|
| Folic Acid | 1 | 2003 | 1300 | 0.140 |
Why?
|
| Down-Regulation | 3 | 2013 | 3002 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2013 | 47 | 0.140 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2013 | 73 | 0.140 |
Why?
|
| Exercise Tolerance | 2 | 2018 | 770 | 0.140 |
Why?
|
| Cyclic GMP | 5 | 2011 | 409 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 15519 | 0.130 |
Why?
|
| Middle Aged | 21 | 2023 | 213383 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 9274 | 0.130 |
Why?
|
| Nitrates | 1 | 1997 | 265 | 0.130 |
Why?
|
| Diet | 1 | 2013 | 7939 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2023 | 1738 | 0.130 |
Why?
|
| Brachial Artery | 1 | 2016 | 369 | 0.130 |
Why?
|
| Caveolin 1 | 1 | 2016 | 263 | 0.130 |
Why?
|
| Renin-Angiotensin System | 2 | 2020 | 759 | 0.130 |
Why?
|
| Adenosine Monophosphate | 1 | 2016 | 275 | 0.120 |
Why?
|
| Swine | 5 | 2017 | 5917 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2008 | 2788 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 314 | 0.120 |
Why?
|
| Endothelin-1 | 2 | 2015 | 314 | 0.120 |
Why?
|
| Thrombophilia | 2 | 2009 | 305 | 0.120 |
Why?
|
| Coronary Restenosis | 1 | 2017 | 424 | 0.120 |
Why?
|
| Heart Failure, Systolic | 1 | 2015 | 126 | 0.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 1184 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2018 | 977 | 0.120 |
Why?
|
| Lipid Peroxidation | 3 | 2012 | 270 | 0.120 |
Why?
|
| Pharmacogenetics | 1 | 2018 | 675 | 0.120 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2017 | 549 | 0.120 |
Why?
|
| Risk Factors | 12 | 2024 | 72290 | 0.120 |
Why?
|
| Exercise Test | 3 | 2020 | 2074 | 0.110 |
Why?
|
| Myocardium | 3 | 2017 | 4776 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 587 | 0.110 |
Why?
|
| Demography | 1 | 2018 | 1656 | 0.110 |
Why?
|
| Stents | 1 | 2005 | 3280 | 0.110 |
Why?
|
| Aspirin | 1 | 2005 | 3282 | 0.110 |
Why?
|
| United States | 11 | 2021 | 69872 | 0.110 |
Why?
|
| Peptides | 1 | 2005 | 4409 | 0.110 |
Why?
|
| Genetic Vectors | 2 | 2019 | 3420 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 2015 | 514 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2020 | 4161 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15295 | 0.100 |
Why?
|
| Pentosephosphates | 1 | 2011 | 6 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 9959 | 0.100 |
Why?
|
| Glucose-6-Phosphate | 1 | 2011 | 30 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 496 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2015 | 8324 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 850 | 0.100 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 1637 | 0.100 |
Why?
|
| Hyperhomocysteinemia | 2 | 2003 | 124 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 875 | 0.100 |
Why?
|
| Myocardial Contraction | 3 | 2014 | 1585 | 0.100 |
Why?
|
| Mice | 19 | 2020 | 81183 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15076 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 7913 | 0.100 |
Why?
|
| Catheterization | 1 | 2016 | 1470 | 0.100 |
Why?
|
| Sulfhydryl Compounds | 1 | 2012 | 298 | 0.100 |
Why?
|
| S-Nitrosothiols | 1 | 2010 | 35 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 4420 | 0.090 |
Why?
|
| Thrombolytic Therapy | 2 | 2001 | 2161 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2020 | 1107 | 0.090 |
Why?
|
| Cell Movement | 3 | 2020 | 5217 | 0.090 |
Why?
|
| Models, Biological | 4 | 2020 | 9583 | 0.090 |
Why?
|
| Drug Approval | 1 | 2016 | 742 | 0.090 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2010 | 144 | 0.090 |
Why?
|
| Dehydroepiandrosterone | 2 | 2001 | 252 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2003 | 433 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1058 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4751 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 1416 | 0.090 |
Why?
|
| Life Style | 1 | 2021 | 3835 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1119 | 0.090 |
Why?
|
| Adult | 11 | 2024 | 214055 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 6489 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2011 | 2508 | 0.090 |
Why?
|
| Aged | 17 | 2023 | 163280 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1620 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2014 | 2297 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2013 | 653 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2017 | 1248 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2012 | 491 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 315 | 0.080 |
Why?
|
| Catalase | 2 | 2009 | 222 | 0.080 |
Why?
|
| Time Factors | 6 | 2021 | 40075 | 0.080 |
Why?
|
| Echocardiography | 3 | 2022 | 5102 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2703 | 0.080 |
Why?
|
| Age Distribution | 1 | 2014 | 2902 | 0.080 |
Why?
|
| Mitochondria, Liver | 1 | 2009 | 187 | 0.080 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2009 | 102 | 0.080 |
Why?
|
| Nitric Oxide Donors | 2 | 2009 | 121 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 21827 | 0.080 |
Why?
|
| Genotype | 3 | 2020 | 12951 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1889 | 0.080 |
Why?
|
| Stroke Volume | 2 | 2018 | 5007 | 0.080 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2007 | 23 | 0.080 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 475 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4560 | 0.080 |
Why?
|
| Cysteine | 1 | 2012 | 874 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.070 |
Why?
|
| Selenoproteins | 1 | 2009 | 216 | 0.070 |
Why?
|
| Inflammation | 3 | 2021 | 10638 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2009 | 295 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2013 | 2499 | 0.070 |
Why?
|
| Hemorrhagic Disorders | 1 | 2006 | 36 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8037 | 0.070 |
Why?
|
| COS Cells | 1 | 2009 | 1161 | 0.070 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2007 | 87 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2013 | 3144 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2109 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 300 | 0.070 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 248 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2018 | 6544 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2020 | 4286 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2010 | 5179 | 0.070 |
Why?
|
| Tomography, Optical Coherence | 2 | 2017 | 2657 | 0.070 |
Why?
|
| Prognosis | 4 | 2020 | 29063 | 0.070 |
Why?
|
| Albuminuria | 1 | 2009 | 682 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2006 | 534 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2018 | 3444 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10943 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2007 | 1581 | 0.060 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2005 | 71 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 1573 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2019 | 1686 | 0.060 |
Why?
|
| Allopurinol | 1 | 2006 | 191 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2005 | 132 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1534 | 0.060 |
Why?
|
| Mice, Knockout | 7 | 2020 | 14557 | 0.060 |
Why?
|
| Triazenes | 1 | 2003 | 8 | 0.060 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.060 |
Why?
|
| Premedication | 1 | 2005 | 258 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1526 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2003 | 41 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2017 | 8554 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 893 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4204 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 1602 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 1783 | 0.060 |
Why?
|
| Xanthine | 1 | 2003 | 11 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 57776 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2007 | 1682 | 0.060 |
Why?
|
| Complement C3 | 2 | 2020 | 461 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2016 | 12026 | 0.060 |
Why?
|
| Kynurenine | 1 | 2023 | 139 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4468 | 0.050 |
Why?
|
| Aging | 2 | 2020 | 8664 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2020 | 21746 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 8642 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2016 | 3864 | 0.050 |
Why?
|
| Retrospective Studies | 9 | 2024 | 77449 | 0.050 |
Why?
|
| Arteriosclerosis | 3 | 2002 | 1092 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3610 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2010 | 2740 | 0.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2011 | 707 | 0.050 |
Why?
|
| Nitroglycerin | 1 | 2003 | 325 | 0.050 |
Why?
|
| DNA Primers | 1 | 2007 | 2892 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2216 | 0.050 |
Why?
|
| Veterans | 1 | 2016 | 2519 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 597 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 891 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 397 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2005 | 881 | 0.050 |
Why?
|
| Mutation | 4 | 2018 | 29786 | 0.050 |
Why?
|
| Mice, Mutant Strains | 4 | 2009 | 1866 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 772 | 0.050 |
Why?
|
| Pteridines | 1 | 2001 | 45 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 478 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2016 | 9146 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2008 | 6442 | 0.050 |
Why?
|
| Glutathione Reductase | 1 | 2000 | 25 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.050 |
Why?
|
| Creatinine | 1 | 2006 | 1919 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2009 | 1373 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 12261 | 0.050 |
Why?
|
| Shear Strength | 1 | 2021 | 165 | 0.050 |
Why?
|
| Tyrosine | 3 | 2016 | 1461 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2000 | 93 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 203 | 0.050 |
Why?
|
| Dinoprost | 2 | 2016 | 138 | 0.050 |
Why?
|
| Secretory Pathway | 1 | 2020 | 51 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2004 | 476 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15540 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1137 | 0.050 |
Why?
|
| Complement Factor B | 1 | 2020 | 72 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1438 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2016 | 6256 | 0.040 |
Why?
|
| Liver | 2 | 2016 | 7474 | 0.040 |
Why?
|
| Cytosol | 1 | 2003 | 901 | 0.040 |
Why?
|
| Cell Line | 4 | 2010 | 15997 | 0.040 |
Why?
|
| Pyrophosphatases | 1 | 2020 | 137 | 0.040 |
Why?
|
| Complement C5 | 1 | 2020 | 112 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2006 | 1301 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5867 | 0.040 |
Why?
|
| Hospitalization | 2 | 2018 | 10262 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 126 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1782 | 0.040 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2020 | 197 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 9648 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 531 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2020 | 160 | 0.040 |
Why?
|
| Exercise | 1 | 2015 | 5615 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2016 | 5751 | 0.040 |
Why?
|
| Cell Survival | 3 | 2016 | 5882 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 336 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2006 | 2170 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6234 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6622 | 0.040 |
Why?
|
| Women's Health | 1 | 2008 | 2034 | 0.040 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2020 | 382 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20129 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2564 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6365 | 0.040 |
Why?
|
| Smad3 Protein | 1 | 2018 | 180 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15226 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2003 | 688 | 0.040 |
Why?
|
| Hemostasis | 2 | 2002 | 458 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2017 | 193 | 0.040 |
Why?
|
| Parasympathomimetics | 1 | 2016 | 26 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2020 | 324 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2012 | 11483 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 1616 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39050 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 489 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 65 | 0.040 |
Why?
|
| Rabbits | 1 | 2003 | 4894 | 0.040 |
Why?
|
| Isoindoles | 1 | 2016 | 41 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4933 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2011 | 1155 | 0.040 |
Why?
|
| Gene Expression | 2 | 2020 | 7799 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2001 | 841 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1434 | 0.040 |
Why?
|
| Methacholine Chloride | 1 | 2016 | 233 | 0.040 |
Why?
|
| Plethysmography | 1 | 2016 | 180 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2020 | 881 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 903 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2024 | 1167 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 93 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 104 | 0.030 |
Why?
|
| Resistin | 1 | 2016 | 170 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 3508 | 0.030 |
Why?
|
| Streptokinase | 1 | 1995 | 188 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2010 | 2208 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2016 | 520 | 0.030 |
Why?
|
| Cell Division | 1 | 2003 | 4568 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 873 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 1655 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 1912 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2149 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 573 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2006 | 2647 | 0.030 |
Why?
|
| Heart | 2 | 2022 | 4467 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1995 | 336 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 780 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 1420 | 0.030 |
Why?
|
| Forearm | 1 | 2016 | 409 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 3701 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2016 | 40561 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2016 | 361 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 764 | 0.030 |
Why?
|
| Aerosols | 1 | 2016 | 625 | 0.030 |
Why?
|
| Arteries | 1 | 2018 | 1119 | 0.030 |
Why?
|
| Registries | 2 | 2006 | 8089 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5892 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 2124 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 2148 | 0.030 |
Why?
|
| Protein Transport | 2 | 2012 | 1988 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 3505 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3870 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1850 | 0.030 |
Why?
|
| Kinetics | 1 | 2020 | 6473 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 638 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 2073 | 0.030 |
Why?
|
| Oxygen | 1 | 2023 | 4189 | 0.030 |
Why?
|
| Adolescent | 3 | 2016 | 85781 | 0.030 |
Why?
|
| Thiamine | 1 | 2012 | 152 | 0.030 |
Why?
|
| Angiography | 1 | 2017 | 1639 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2011 | 12208 | 0.020 |
Why?
|
| Length of Stay | 1 | 2005 | 6309 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2011 | 89 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2014 | 620 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2012 | 964 | 0.020 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2011 | 124 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 2029 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2024 | 23338 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 2649 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2005 | 7880 | 0.020 |
Why?
|
| Mitochondria | 1 | 2003 | 3520 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2017 | 2110 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 393 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 252 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 4931 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 425 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 480 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 443 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 212 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 229 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2009 | 23 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2009 | 186 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2012 | 572 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3588 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2009 | 45 | 0.020 |
Why?
|
| Nitroso Compounds | 1 | 2009 | 72 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2915 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2009 | 112 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2016 | 849 | 0.020 |
Why?
|
| Microvessels | 1 | 2013 | 544 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 225 | 0.020 |
Why?
|
| Heterozygote | 2 | 2009 | 2804 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1486 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2009 | 255 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1584 | 0.020 |
Why?
|
| Insulin | 2 | 2016 | 6580 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 12354 | 0.020 |
Why?
|
| Triglycerides | 1 | 2016 | 2454 | 0.020 |
Why?
|
| P-Selectin | 1 | 2011 | 600 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 2503 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2016 | 13033 | 0.020 |
Why?
|
| Selenocysteine | 1 | 2009 | 124 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2925 | 0.020 |
Why?
|
| Placenta | 1 | 2017 | 1698 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 798 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 905 | 0.020 |
Why?
|
| Cholesterol | 1 | 2016 | 2917 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2011 | 8436 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4599 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1706 | 0.020 |
Why?
|
| Sex Factors | 1 | 2001 | 10397 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 1632 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2006 | 95 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2006 | 169 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 708 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 1026 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 913 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 11725 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12959 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1986 | 179 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 3340 | 0.020 |
Why?
|
| Nitroprusside | 2 | 2000 | 275 | 0.020 |
Why?
|
| Homozygote | 1 | 2009 | 1785 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2009 | 1099 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 1227 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 1211 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2016 | 3279 | 0.020 |
Why?
|
| Mortality | 1 | 2016 | 2864 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2004 | 41 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 8663 | 0.010 |
Why?
|
| Ribose | 1 | 2004 | 68 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1970 | 0.010 |
Why?
|
| Glycine | 1 | 2007 | 671 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19905 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 504 | 0.010 |
Why?
|
| Recurrence | 1 | 1995 | 8340 | 0.010 |
Why?
|
| Arginine | 1 | 2007 | 944 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2005 | 569 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2016 | 5985 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 2025 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2003 | 547 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 2002 | 354 | 0.010 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2000 | 27 | 0.010 |
Why?
|
| F2-Isoprostanes | 1 | 2000 | 35 | 0.010 |
Why?
|
| Lipid Peroxides | 1 | 2000 | 73 | 0.010 |
Why?
|
| Stroke | 1 | 2022 | 9981 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2006 | 1299 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2000 | 621 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7722 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 25625 | 0.010 |
Why?
|
| Ischemia | 1 | 2005 | 1907 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35421 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13284 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 35136 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 29144 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 9734 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 41006 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 1203 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3748 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1999 | 1151 | 0.010 |
Why?
|
| Proteins | 1 | 2007 | 6103 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2003 | 9849 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2003 | 5317 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1986 | 124 | 0.000 |
Why?
|
| Mesenteric Arteries | 1 | 1986 | 183 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1986 | 719 | 0.000 |
Why?
|
| Microspheres | 1 | 1986 | 777 | 0.000 |
Why?
|
| Perfusion | 1 | 1986 | 1360 | 0.000 |
Why?
|
| Cell Communication | 1 | 1986 | 1621 | 0.000 |
Why?
|